MCM3 and breast cancer: In this study, quantitative proteomic analysis revealed upregulation of MCM3 in tamoxifen- and AI-resistant breast cancer cells and knockdown of MCM3 resensitized these cells to tamoxifen or letrozole and resulted in altered phosphorylation of cell cycle regulator proteins.